Controlled Substances (DEA) Compliance & Enforceme

Covers legal and regulatory issues involving controlled substances under the Controlled Substances Act and DEA rules, including registration, prescribing/dispensing, recordkeeping, security, quotas, and reporting. Also addresses DEA inspections, investigations, enforcement actions, administrative proceedings, and related civil or criminal liability for healthcare providers, pharmacies, manufacturers, distributors, and researchers.

1 post

DEA Compliance Mistakes That Put Pharmaceutical Businesses at Risk

May 25, 2026 • By Guest Post

DEA compliance mistakes can trigger civil fines, loss of DEA registration, and shutdowns after audits or inspections. Common risks include inventory/recordkeeping gaps, poor suspicious order monitoring, and inadequate storage/security controls. This article outlines frequent pitfalls across the controlled-substance supply chain and practical steps to prevent enforcement actions. Pharmaceutical businesses that handle controlled substances operate under […]